These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1698341)

  • 1. Epitheliosis of the breast. An immunohistochemical characterization and comparison to malignant intraductal proliferations of the breast.
    Raju U; Crissman JD; Zarbo RJ; Gottlieb C
    Am J Surg Pathol; 1990 Oct; 14(10):939-47. PubMed ID: 1698341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of keratin 35betaE12 as an adjunct in the diagnosis of mammary intraepithelial neoplasia-ductal type--benign and malignant intraductal proliferations.
    Moinfar F; Man YG; Lininger RA; Bodian C; Tavassoli FA
    Am J Surg Pathol; 1999 Sep; 23(9):1048-58. PubMed ID: 10478664
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An immunohistochemical study of the breast using antibodies to basal and luminal keratins, alpha-smooth muscle actin, vimentin, collagen IV and laminin. Part II: Epitheliosis and ductal carcinoma in situ.
    Böcker W; Bier B; Freytag G; Brömmelkamp B; Jarasch ED; Edel G; Dockhorn-Dworniczak B; Schmid KW
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(4):323-30. PubMed ID: 1384227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spindle cell ductal carcinoma in situ. An unusual variant of ductal intra-epithelial neoplasia that simulates ductal hyperplasia or a myoepithelial proliferation.
    Farshid G; Moinfar F; Meredith DJ; Peiterse S; Tavassoli FA
    Virchows Arch; 2001 Jul; 439(1):70-7. PubMed ID: 11499843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.
    Tsang WY; Chan JK
    Am J Surg Pathol; 1996 Aug; 20(8):921-43. PubMed ID: 8712293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histopathology of myoepithelial (basocellular) hyperplasias in adenosis and epitheliosis of the breast demonstrated by the reactivity of cytokeratins and S100 protein. An analysis of heterogenic cell proliferations in 90 cases of benign and malignant breast diseases.
    Bässler R; Katzer B
    Virchows Arch A Pathol Anat Histopathol; 1992; 421(5):435-42. PubMed ID: 1280883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Papillary neoplasia of the breast: immunohistochemically defined myoepithelial cells in the diagnosis of benign and malignant papillary breast neoplasms.
    Raju UB; Lee MW; Zarbo RJ; Crissman JD
    Mod Pathol; 1989 Nov; 2(6):569-76. PubMed ID: 2479944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinicopathologic study of infiltrating epitheliosis of the breast].
    Xu XL; Tu XY; Shui RH; Cheng YF; Yu BH; Yang WT
    Zhonghua Bing Li Xue Za Zhi; 2017 Dec; 46(12):827-831. PubMed ID: 29224275
    [No Abstract]   [Full Text] [Related]  

  • 9. Myoepithelial cells in the differential diagnosis of complex benign and malignant breast lesions: an immunohistochemical study.
    Gottlieb C; Raju U; Greenwald KA
    Mod Pathol; 1990 Mar; 3(2):135-40. PubMed ID: 1691493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Actin-rich (myoepithelial) cells in ductal carcinoma-in-situ of the breast.
    Bussolati G; Botta G; Gugliotta P
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1980; 34(3):251-9. PubMed ID: 6108644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of keratin expression and actin distribution in benign and malignant mammary diseases.
    Wada T; Yasutomi M; Yamada K; Hashimura K; Kunikata M; Tanaka T; Huang JW; Mori M
    Anticancer Res; 1991; 11(6):1983-93. PubMed ID: 1723260
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical differentiation of atypical hyperplasia vs. carcinoma in situ of the breast.
    Masood S; Sim SJ; Lu L
    Cancer Detect Prev; 1992; 16(4):225-35. PubMed ID: 1281040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ductal carcinoma in situ with spindle cells: a potential diagnostic pitfall in the evaluation of breast lesions.
    Tan PH; Lui GG; Chiang G; Yap WM; Poh WT; Bay BH
    Histopathology; 2004 Oct; 45(4):343-51. PubMed ID: 15469472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal epithelial proliferations of the breast: a biological continuum? Comparative genomic hybridization and high-molecular-weight cytokeratin expression patterns.
    Boecker W; Buerger H; Schmitz K; Ellis IA; van Diest PJ; Sinn HP; Geradts J; Diallo R; Poremba C; Herbst H
    J Pathol; 2001 Nov; 195(4):415-21. PubMed ID: 11745672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytological criteria for the diagnosis of intraductal hyperplasia, ductal carcinoma in situ, and invasive carcinoma of the breast.
    Bofin AM; Lydersen S; Hagmar BM
    Diagn Cytopathol; 2004 Oct; 31(4):207-15. PubMed ID: 15452908
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoreactivity of ductal cells with putative myoepithelial markers: A potential pitfall in breast carcinoma.
    Nayar R; Breland C; Bedrossian U; Masood S; DeFrias D; Bedrossian CW
    Ann Diagn Pathol; 1999 Jun; 3(3):165-73. PubMed ID: 10359852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin 5/6 immunohistochemistry assists the differential diagnosis of atypical proliferations of the breast.
    Otterbach F; Bànkfalvi A; Bergner S; Decker T; Krech R; Boecker W
    Histopathology; 2000 Sep; 37(3):232-40. PubMed ID: 10971699
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical evaluation of the cytoarchitecture of benign and malignant breast lesions.
    Soini Y; Miettinen M
    APMIS; 1992 Oct; 100(10):901-7. PubMed ID: 1280148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Infiltrating epitheliosis of the breast: characterization of histological features, immunophenotype and genomic profile.
    Eberle CA; Piscuoglio S; Rakha EA; Ng CK; Geyer FC; Edelweiss M; Sakr RA; Weigelt B; Reis-Filho JS; Ellis IO
    Histopathology; 2016 Jun; 68(7):1030-9. PubMed ID: 26497122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical study of matrix metalloproteinase 9 and tissue inhibitor of matrix metalloproteinase 1 in benign and malignant breast tissue--strong expression in intraductal carcinomas of the breast.
    Rahko E; Kauppila S; Pääkkö P; Blanco G; Apaja-Sarkkinen M; Talvensaari-Mattila A; Turpeenniemi-Hujanen T; Jukkola A
    Tumour Biol; 2009; 30(5-6):257-64. PubMed ID: 19887890
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.